T-cell education in autoimmune diabetes: Teachers and students

Trends in Immunology

Volumn 23, Issue 1, 2002, Pages 40-46

  Rosmalen, Judith G M ^a   Van Ewijk, Willem ^b   Leenen, Pieter J M ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CELL DEATH; DISEASE PREDISPOSITION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; THYMOCYTE; THYMUS FUNCTION;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENES, MHC CLASS I; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED NOD; RATS; RATS, INBRED BB; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0036152560     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)02088-9     Document Type: Review

References (59)

1. Abnormal T-cell selection on NOD thymic epithelium is sufficient to induce autoimmune manifestations in C57BL/6 athymic nude mice
2. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities
3. g7 molecules from nonobese diabetic mice are poor peptide binders
4. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions
5. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes
6. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats
7. A new look at MHC and autoimmune disease
8. HLA associations in type 1 diabetes: Merging genetics and immunology
9. Studies on the thymus in nonobese diabetic mouse. I. Changes in the microenvironmental compartments
10. Mechanisms of tolerance to self
11. Development, organization and function of the thymic medulla in normal, immunodeficient or autoimmune mice
12. Thymic epithelial defects and predisposition to autoimmune disease in BB rats
13. g7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder
14. g7 of NOD mouse: pH-dependent changes in specificity at pockets 9 and 6 explain several of the unique properties of this molecule
15. + thymocytes by protective MHC class II molecules
16. Type-1-diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD)-65-specific T cells in a transgenic model
17. Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter
18. Antigen processing and autoimmunity. Evaluation of mRNA abundance and function of HLA-linked genes
19. NOD mice are defective in proteasome production and activation of NF-κB
20. Reply to 'LMP2 expression and proteasome activity in NOD mice'
21. Thymic T-cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T-cell-receptor regulation of the pathway of p21ras activation
22. T-cell energy and altered T-cell-receptor signaling: Effects on autoimmune disease
23. Resistance of T cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x
24. The lymphopenia mutation of the BB rat causes inappropriate apoptosis of mature thymocytes
25. g7-dependent reaction
26. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains
27. Defects in the differentiation and function of antigen-presenting cells in NOD/Lt mice
28. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T-cell activation and CTLA-4 up-regulation
29. Splenic dendritic cells from the nonobese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?
30. A defect in bone-marrow-derived dendritic-cell maturation in the nonobese diabetic mouse
31. Signs of immaturity of splenic dendritic cells from the autoimmune-prone Biobreeding rat: Consequences for the in vitro expansion of regulator and effector T cells
32. Homotypic cluster formation of dendritic cells, a close correlate of their state of maturation. Defects in the Biobreeding diabetes-prone rat
33. Impaired yield, phenotype and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes
34. Impaired CD4 T-cell activation due to reliance upon B-cell-mediated costimulation in nonobese diabetic (NOD) mice
35. Enhanced metabolism of arachidonic acid by macrophages from nonobese diabetic (NOD) mice
36. Immune dysfunction in diabetes-prone BB rats. Interleukin-2 production and other mitogen-induced responses are suppressed by activated macrophages
37. Aberrant prostaglandin synthase 2 expression defines an antigen-presenting-cell defect for insulin-dependent diabetes mellitus
38. Interleukin-4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
39. CD28 co-stimulation restores T-cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription
40. Defective T-cell receptor/CD3 complex signaling in human type I diabetes
41. Specific deficiency of p56lck expression in T lymphocytes from type 1 diabetic patients
42. Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T and B cells in IDDM
43. The identification of a novel T-cell activation state controlled by a diabetogenic gene
44. + T-cell peripheral tolerance in nonobese diabetic mice
45. Diabetes prone BB rats are severely deficient in natural killer T cells
46. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
47. Cytometric and functional analyses of NK- and NK-T-cell deficiencies in NOD mice
48. NK-T-cell-induced protection against diabetes in Vα14-Jα281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen
49. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes
50. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation
51. The influence of T-lymphocyte precursor cells and thymus grafts on the cellular immunodeficiencies of the BB rat
52. Comparison of high- and low-diabetes-incidence NOD mouse strains
53. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: Additive, but unequal, involvement of multiple APC subtypes
54. g7-transgenic nonobese diabetic mouse line
55. g7 on a nonobese diabetic versus C57BL/6 genetic background
56. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: Elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor α and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice
57. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-κB regulation due to a hyperactive IκB kinase
58. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL-12B allele
59. Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: Caveat emptor and primum non nocere